Skip to main content
Log in

Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

In this study the production of enterotoxin A-D and toxic shock syndrome toxin-1 (TSST-1) of 181 methicillin resistant (MRSA) and 100 methicillin sensitive (MSSA) Staphylococcus aureus first isolates from different patients was investigated. All the MRSA- and MSSA isolates in the study were collected in a period between 1993 and 1995 from specimens sent from 11 different acute care hospitals in the greater Düsseldorf area. As far as possible the isolates were matched according to ward and hospital. The isolates were collected in the same time period and matched for specimen from which isolated. Furthermore, only first isolates were analysed in both groups. No significant difference in the production of toxin of any type between MRSA and MSSA could be detected (51 and 40% respectively). When the individual toxins were analysed, again no significant difference between MRSA and MSSA was demonstrable (enterotoxin production by MRSA 40% and MSSA 36%, and TSST-1 16% and 8% respectively). Despite this, a slight tendency for MRSA to produce enterotoxin A and B and for MSSA to produce enterotoxin C was observed. In addition, generation of TSST-1 by both groups was independent of enterotoxin A-D production. Interestingly, no increase in the proportion of TSST-1- or enterotoxin-producing MRSA and MSSA isolates was observed in strains isolated from blood cultures from patients with a clinical diagnosis of sepsis. Genotypical pulsed-field-gel-electrophoresis (PFGE) and phenotypical (bacteriophage typing, lysotyping) characterization of the 181 MRSA isolates resulted in 28 different PFGE patterns (of which 19 were toxin producers) and 22 lysotyping groups (18 of which produced toxin). In summary, the investigated clinical S. aureus isolates showed no difference in their ability to produce toxin and this was independent of their sensitivity to methicillin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med 1989; 320: 1188–1196.

    Google Scholar 

  2. Eadon HJ, Pinney RJ. Methicillin resistant Staphylococcus aureus: An overview. J Clin Pharm Ther 1991; 16: 453–462.

    Google Scholar 

  3. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. J Clin Microbiol 1993; 6: 428–442.

    Google Scholar 

  4. Martone WJ, Jarvis WR, Culver DH, Haley RW. Incidence and nature of endemic and epidemic nosocomial infections. In: Bennett JV, Brachman PS (eds), Hospital infections. Boston: Little, Brown and Co., 1992: 577–596.

    Google Scholar 

  5. Mauff G. Epidemiologie Hbertragbarer Krankheiten. In: Brandis H, Eggers HJ, Köhler W, Pulverer G (eds), Lehrbuch der Medizinischen Mikrobiologie. Stuttgart: Gustav Fischer Verlag, 1994: 48–63.

    Google Scholar 

  6. Mulligan ME, Murray KA, Ripner BS, Standifort HC, John JF, Corvick JA, et al. Methicillin resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993; 94: 313–328.

    Google Scholar 

  7. Panlilio A, Culver DH, Gayns RP, Banerjee S, Henderson TS, Tolson JS, et al. Methicillin resistant Staphylococcus aureus in US hospitals, 1975–1991. Infect Control Hosp Epidemiol 1992; 13: 582–586.

    Google Scholar 

  8. Voss A, Machka K, Lenz W, Milatovic D. Vorkommen, Häufigkeit und Resistenzverhalten von Methicillin-resistenten Staphylococcus aureus-Stämmen in Deutschland. DMW 1992; 117: 1907–1912.

    Google Scholar 

  9. Peters G, Pulverer G. Die Familie der Micrococcaceae. In: Brandis H, Eggers HJ, Köhler W, Pulverer G (eds), Lehrbuch der Medizinischen Mikrobiologie. Stuttgart: Gustav Fischer Verlag, 1994: 350–360.

    Google Scholar 

  10. Coia JE, Browning L, Haines L, Birkbeck TH, Platt DJ. Comparison of enterotoxins and haemolysins produced by methicillin-resistant (MRSA) and sensitive (MSSA) Staphylococcus aureus. J Med Microbiol 1992; 36: 164–171.

    Google Scholar 

  11. Duckworth GJ, Oppenheim BA. Enterotoxin production in epidemic Methicillin resistant Staphylococcus aureus. Lancet 1986 (i): 565–566.

    Google Scholar 

  12. Jordens JZ, Druckworth GJ, Williams RJ. Production of ‘virulence factors’ by ‘epidemic’ methicillin-resistant Staphylococcus aureus in vitro. J Med Microbiol 1989; 30: 245–252.

    Google Scholar 

  13. Mizobuchi S, Minami J, Jin F, Matsushita O, Okabe A. Comparison of the virulence of Methicillin resistant and Methicillin sensitive Staphylococcus aureus. Microbiol Immunol 1994; 38: 599–605.

    Google Scholar 

  14. Rossney AS, Coleman DC, Keane CT. Antibiogram-resistogram typing scheme for methicillin resistant Staphylococcus aureus. J Med Microbiol 1994; 41: 430–440.

    Google Scholar 

  15. Lacey RW. Multi-resistant Staphylococcus aureus: A suitable case for inactivity? J Hosp Infect 1987; 9: 103–105.

    Google Scholar 

  16. Collopy BT, Dalton M, Wright C, Mullany C. Comparison of the clinical significance of methicillin-resistant and methicillin-sensitive Staphylococcus aureus. Med J Australia 1984; 140: 211–214.

    Google Scholar 

  17. Gedney J, Lacey RW. Properties of methicillin-resistant staphylococci now endemic in Australia. Med J Aust 1982; 1: 448–450.

    Google Scholar 

  18. Muder RR, Brennen C, Wagener M. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991; 114: 107–112.

    Google Scholar 

  19. Schmitz FJ, MacKenzie CR, Geisel R, Wagner S, Idel H, Hadding U, Heinz HP. Methicillin resistant Staphylococcus aureus strains in the greater Düsseldorf area. Eur J Epidemiol 1997; 13.

  20. Deutsches Institut für Normung. Empfindlichkeitsprüfung von Krankheitserregern gegen Chemotherapeutika. In: DIN-Taschenbuch Medizinische Mikrobiologie und Immunologie. Berlin: Beuth, 1992: 331–406.

    Google Scholar 

  21. Wieneke AA. The detection of enterotoxin and toxic shock syndrome toxin-1 production by strains of Staphylococcus aureus with commercial RPLA kits. Int J Food Microbiol 1988; 7: 25–30.

    Google Scholar 

  22. Goering RV. Molecular epidemiology of nosocomial infection: analysis of chromosomal restriction fragment patterns by pulsed-field gel electrophoresis. Infect Control Hosp Epidemiol 1993; 14: 595–600.

    Google Scholar 

  23. Schmitz FJ, Geisel R, Wagner S, Heinz HP, Idel H, Hadding U. Standardisierte Puls-Feld-Gel-Elektrophorese mit dem GenePath Strain Typing Sytsem zum DNA-Fingerprinting bei nosokomialen Infektionen. Lab Med 1995; 19: 512–522.

    Google Scholar 

  24. Römling U, Fislage R, Tümmler B. Theorie und Anwendung der Makrorestriktionsanalyse für die klonale Analyse von Erregern. Immun Infekt 1995; 23: 4–8.

    Google Scholar 

  25. Bannerman TL, Hancock GA, Tenover FC, Miller JM. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J Clin Microbiol 1995; 33: 551–555

    Google Scholar 

  26. Lenz W, Brandis H. Die Bedeutung der Lysotypie bei Krankenhausinfektionen durch Staphylococcus aureus. Hyg Med 1985; 10: 227–238.

    Google Scholar 

  27. Lenz W. Die Staphylokokkn-Lysotypie als epidemiologisches Werkzeug. Hyg Med 1991; 16: 197–214.

    Google Scholar 

  28. DeBoer ML, Chow AW. Toxic shock syndrome toxin-1 producing Staphylococcus aureus isolates contain the staphylococcal enterotoxin B genetic element but do not express styphylococcal enterotoxin B. J Infect Dis 1994; 170: 818–827.

    Google Scholar 

  29. Vergeront JM, Stolz SJ, Crass, BA, Nelson DB, Davis JP, Bergdoll MS. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents implications for toxic shock syndrome. J Infect Dis 1983; 148: 692–698.

    Google Scholar 

  30. Bohach GA, Kreiswirth BN, Novick RP, Schlievert PM. Analysis of TSS isolates producing staphylococcal enterotoxins B and C1 with use of Southern hybridization and immunological assays. Rev Infect Dis 1989; 1: S75–S81.

    Google Scholar 

  31. Marples RR, Wieneke AA. Enterotoxins and toxic shock syndrome toxin-1 in non-enteric staphylococcal disease. Epidemiol Infect 1993; 110: 477–488.

    Google Scholar 

  32. Crass BA, Bergdoll MS. Involvement of staphylococcal enterotoxins in non-menstrual toxic shock syndrom. J Clin Microbiol 1986; 23: 1138–1139.

    Google Scholar 

  33. Rott O, Fleischer B. A superantigen as virulence factor in an acute bacterial infection. J Infect Dis 1994; 169: 1042–1046.

    Google Scholar 

  34. Schlievert PM, Shands KN, Dan DB, Schmid GP, Nishimura RD. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome. J Infect Dis 1981; 143: 509–516.

    Google Scholar 

  35. Kreiswirth BN, Projan SJ, Schlievert PM, Novick RP. Toxic shock syndrome toxin-1 is encoded by a variable genetic element. Rev Infect Dis 1989; 11: S83–S89.

    Google Scholar 

  36. Miethke T, Duschek K, Wahl C, Heeg K, Wagner H. Pathogenesis of the toxic shock syndrome: T-cell mediated lethal shock caused by the superantigen TSST 1. Eur J Immunol 1993; 23: 1494–1500.

    Google Scholar 

  37. Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin "superantigens’ with human T cells. Proc Natl Acad Sci USA 1989; 86: 8941–8945.

    Google Scholar 

  38. Parsonnet J, Gillis ZA. Production of tumor necrosis factor by human monocytes in response to toxic shock syndrome toxin-1. J Infect Dis 1988; 158: 1026–1033.

    Google Scholar 

  39. Parsonnet J, Hickman RK, Eardley DD, Pier GB. Induction of human interleukin-1 by toxic shock syndrom toxin-1. J Infect Dis 1985; 151: 514–522.

    Google Scholar 

  40. Schlievert PM. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1986 (ii): 1149–1150.

    Google Scholar 

  41. Ejlertsen T, Jensen A, Lester A, Rosdahl VT. Epidemiology of toxic shock syndrom toxin-1 production in Staphylococcus aureus strains isolated in Denmark between 1959–1990. Scand J Infect Dis 1994; 26: 599–604.

    Google Scholar 

  42. Recsei P, Kreiswirth B, O'Reilley M, Schlievert P, Gruss A, Novick RP. Regulation of exoprotein gene expression in Staphylococcus aureus by agr. Mol Gen Genet 1986; 202: 58–61.

    Google Scholar 

  43. Edwards-Jones V, Foster HA. The effect of topical antimicrobial agents on the production of toxic shock syndrome toxin-1. J Med Microbiol 1994; 41: 408–413.

    Google Scholar 

  44. Reiser RF, Denzin LK, Bergdoll MS. Effects of blood and different media on the production of toxic shock syndrome toxin-1 by Staphylococcus aureus in the tampon sac method. J Med Microbiol 1988; 26: 2672–2674.

    Google Scholar 

  45. Sarafian SK, Morse SA. Environmental factors affecting toxic shock syndrome toxin-1 (TSST-1) synthesis. J Med Microbiol 1987; 24: 75–81.

    Google Scholar 

  46. Wong ACL, Bergdoll MS. Effect of environmental conditions on production of toxic shock syndrome toxin 1 by Staphylococcus aureus. Infect Immun 1990; 58: 1026–1029.

    Google Scholar 

  47. Lehn N, Schaller E, Wagner H, Kronke M. Frequency of toxic shock syndrome toxin-and enterotoxin producing clinical isolates of Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1995; 14: 43–46.

    Google Scholar 

  48. Chang AH, Musser JM, Chow AW. A single clone which produces both TSST-1 and SEA causes a majority of menstrual TSS [Abstract]. Clin Res 1989; 39: 36A.

    Google Scholar 

  49. Humphreys H, Keane CT, Hone R. Enterotoxin production by Staphylococcus aureus isolates from cases of septicaemia and from healthy carriers. J Med Microbiol 1989; 28: 163–172.

    Google Scholar 

  50. Arbuthnot JP, Coleman DC, de Azavedo JS. Staphylococcal toxins in human disease. J Appl Bact Symp Suppl 1990: S101–S107.

  51. Roder BL, Eriksen NHR, Nielsen LP, Slotsbjerg T, Rosdahland VT, Espersen F. No difference in enterotoxin production among Staphylococcus aureus strains isolated from blood compared with strains isolated from healthy carriers. J Med Microbiol 1995; 42: 43–47.

    Google Scholar 

  52. Overbay B, Franzus BW, Gill L, Dula R, Reagan D. Epidemiology of Mupirocin resistant, Methicillin resistant Staphylococcus aureus (MMRSA): A case control study [Abstract]. ICAAC-Tagungsband 1995: J135.

  53. Hughes J, Mellows G. On the mode of action of pseudomonic acid: Inhibition of protein synthesis in Staphylococcus aureus. J Antibiot 1978; 31: 330–335.

    Google Scholar 

  54. Khambaty FM, Bennett RW, Shaw DB. Application of pulsed field gel electrophoresis to the epidemiological characterization of Staphylococcus intermedius implicated in a food-related outbreak. Epidemiol Infect 1994; 113: 75–81.

    Google Scholar 

  55. Renaul F, Bornstein N, Meugnier H, Forey F, Bes M, Fleurette J. Clonal study of enterotoxin B producing strains of Staphylococcus aureus. Epidemiol Infect 1994; 112: 501–511.

    Google Scholar 

  56. Kreiswirth B, Kornblum J, Arbeit RD, Eisner W, Maslow JN, McGeer A, et al. Evidence for a clonal origin of Methicillin resistance in Staphylococcus aureus. Science 1993; 259: 227–230.

    Google Scholar 

  57. Witte W, Cuny C, Braulke C, Heuck D, Klare I. Überregionale, klonale Ausbreitung von MRSA in Deutschland. Bundesgesundheitsblatt 1994; 37(1): 12–16.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmitz, F.J., MacKenzie, C.R., Geisel, R. et al. Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains. Eur J Epidemiol 13, 699–708 (1997). https://doi.org/10.1023/A:1007357206672

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007357206672

Navigation